Update on strategic partnership with MBM Limited

Source: RNS
RNS Number : 6737E
Jade Road Investments Limited
18 September 2024
 


 

Jade Road Investments Limited

18 September 2024

JADE ROAD INVESTMENTS LIMITED

("Jade Road Investments", "JADE" or the "Company)

Update on strategic partnership with MBM Limited

Further to its announcement on 16 August 2024, Jade Road Investments Limited (AIM: JADE) is pleased to announce that it has today constituted up to £1,000,000 in principal value of convertible loan notes (CLN). The CLN is non-interest bearing, has a maturity of 10 months and is convertible at either the option of noteholders or the Company into JADE shares at a price which is 30% below the lowest closing bid price over the 30 business days prior to the date on which either party notifies the other it wishes to convert. 

Jade has today issued £80,000 in principal value of CLN to MBM, having received such sum from MBM in the timeframe agreed with MBM under the terms of the two firms' strategic partnership.

Further announcements will be released to update on further tranches of the CLN being issued to MBM and others as well as updates on target investment opportunities.

The Board of JADE is excited about the prospects this partnership presents and looks forward to providing further updates in the near future. 

For further information, please contact:

 

Jade Road Investments Limited

 

+44 (0) 778 531 5588

John Croft

 

Zeus Capital Limited - Nominated Adviser

 

+44 (0) 203 829 5000

James Joyce

 

Hybridan LLP - Nominated Broker

 

+44 (0) 20 3764 2341

Claire Louise Noyce

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAXNPFFPLEEA